登录    
  
首页 > 期刊论文 > 论文摘要
ABCC8、CHFRBMP3BLOXPRSS21和RASSF1A基因启动子的甲基化状态可能与3种乳腺癌细胞株对5-FU的敏感性相关
         
The methylation status of ABCC8, CHFR, BMP3B, LOX, PRSS21, and RASSF1A promoters correlate with the sensitivity of three breast cancer cell strains to 5-FU

摘    要
目的: 寻找与乳腺癌细胞株间药物敏感性差异相关的基因启动子CpG岛甲基化异常,为DNA甲基化异常作为临床化疗敏感性预测手段提供依据。方法: 用MTT法测定3种乳腺癌细胞株(Bcap-37、T47D和ZR-75-30)对9种化疗药物(紫杉醇、紫杉特尔、长春瑞宾、5-氟尿嘧啶(5-FU)、双氟去氧胞苷、表阿霉素、丝裂霉素、依立替康和顺铂)的敏感性;同时用甲基化特异性PCR检测23个基因在3种乳腺癌细胞株中的甲基化状态。结果: 受试的3种乳腺癌细胞株仅对5-FU的敏感性有明显差异。其中Bcap-37(IC50:317.386μg/mL)对5-FU相对耐药,而ZR-75-30(IC50:6.676μg/mL)和T47D(IC50:73.076μg/mL)对5-FU相对敏感。23个基因中,有6个基因:ABCC8、CHFRBMP3BLOXPRSS21和RASSF1A在敏感和耐药细胞株中的甲基化状态有差异。其中ABCC8、CHFRBMP3B在5-FU耐药细胞株中呈相对高甲基化状态,而LOXPRSS21和RASSF1A则在对5-FU敏感的细胞株中呈相对高甲基化状态。结论: 本研究所发现的6个基因的甲基化状态可能与乳腺癌细胞株对5-FU化疗敏感性相关,为下一步进行临床评估和机制探讨提供了依据。
标    签 乳腺肿瘤   细胞系   DNA甲基化   抗药性   甲基化特异性聚合酶链反应   Breast neoplasms   Cell lines   DNA methylation   Drug resistance   Methylation specific polymerase chain reaction  
 
Abstract
Objective: To identify the abnormal chemosensitivity-associated DNA methylation pattern of CpG islands in the promoter region of breast cancer cell lines and provide the evidence for using abnormal DNA methylation in predicting the chemosensitivity in clinic. Methods: The MTT/IC50 assay was used to determine the chemosensitivity of the three breast cancer cell lines (Bcap-37, T47D, and ZR-75-30) to each of the nine anticancer drugs (paclitaxel, docetaxel, vinorelbine, 5-fluorouracil, gemcitabine, epirubicin, mitomycin, ironotecan, and cisplatin). DNA methylation profile of CpG islands in the promoter region of 23 genes of the three breast cancer cell lines was tested by methylation specific PCR. Results: The sensitivity of the three breast cancer cell lines to 5-FU showed a significant difference. Bcap-37 cells were relatively tolerant to 5-FU (IC50=317.386μg/mL). ZR-75-30 and T47D were relatively sensitive to 5-FU (IC50=6.676 and 73.076μg/mL, respectively). Out of the 23 genes, the methylation of 6 genes, ABCC8, CHFR, BMP3B, LOX, PRSS21, and RASSF1A, exhibited different patterns between the 5-FU-resistant and sensitive cell lines. The ABCC8, CHFR and BMP3B genes were hypermethylated in the 5-FU-resistant cell line, but LOX, PRSS21, and RASSF1A genes were hypermethylated in the 5-FU-sensitive cell line. Conclusion: There is a promising correlation of the methylation state of 6 genes with the chemosensitivity of the breast cancer cell lines to 5-FU. This study provided the evidence for further clinical evaluation and mechanism exploration.

中图分类号 R737.9 Q754   DOI 10.3781/j.issn.1000-7431.2009.01.005

 
  购买该论文  中国光学期刊网论文下载说明
      


所属栏目 基础研究

基金项目 上海市科委资助项目(编号:07DJ14074);上海市肿瘤医院院外合作项目(编号:YWHZ200601)

收稿日期 2008/3/30

修改稿日期 2008/6/3

网络出版日期

作者单位点击查看


引用该论文: CAI Yang,SUN Jin-feng,HUANG Zhao-hui,YU Jian,HE Ying-hua,DAI Xin-lan,ZHOU Xiao-yu,XU Hui-li,GU Jun,ZHANG Hong-yu,HU Xi-chun,ZHU Jing-de. The methylation status of ABCC8, CHFR, BMP3B, LOX, PRSS21, and RASSF1A promoters correlate with the sensitivity of three breast cancer cell strains to 5-FU[J]. Tumor, 2009, 29(1): 20~25
蔡飏,孙晋枫,黄朝晖,余坚,何英华,戴信兰,周小羽,徐慧莉,顾峻,张红宇,胡夕春,朱景德. ABCC8、CHFRBMP3BLOXPRSS21和RASSF1A基因启动子的甲基化状态可能与3种乳腺癌细胞株对5-FU的敏感性相关[J]. 肿瘤, 2009, 29(1): 20~25


论文评价
共有人对该论文发表了看法,其中:
人认为该论文很差
人认为该论文较差
人认为该论文一般
人认为该论文较好
人认为该论文很好
分享论文
分享到新浪微博 分享到腾讯微博 分享到人人网 分享到 Google Reader 分享到百度搜藏分享到Twitter

参考文献
【1】TEITZ T, WEI T, VALENTINE M B, et al. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN[J]. Nat Med, 2000, 6(5):529-535.
 
【2】AKADA M, CRNOGORAC-JURCEVIC T, LATTIMORE S, et al. Intrinsic chemoresistance to gemcitabine is associated with decreased expression of BNIP3 in pancreatic cancer[J]. Clin Cancer Res, 2005, 11(8):3094-3101.
 
【3】WORM J,KIRKIN A F,DZHANDZHUGAZYAN K N,et al.Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells[J]. J Biol Chem, 2001, 276(43):39990-40000.
 
【4】HANSEN L T, THYKJAER T, ORNTOFT T F, et al. The role of mismatch repair in small-cell lung cancer cells[J]. Eur J Cancer, 2003, 39(10):1456-1467.
 
【5】PLUMB J A, STEELE N, FINN P W, et al. Epigenetic approaches to cancer therapy[J]. Biochem Soc Trans, 2004, 32(Pt 6):1095-1097.
 
【6】HERMAN J G, GRAFF J R, MYOHANEN S, et al. Methylation-specific PCR:a novel PCR assay for methylation status of CpG islands[J]. Proc Natl Acad Sci U S A, 1996, 93(18):9821-9826.
 
【7】YU J, ZHANG H, GU J, et al. Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma[J]. BMC Cancer, 2004, 465.
 
【8】YU J, ZHU T, WANG Z, et al. A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer[J]. Clin Cancer Res, 2007, 13(24):7296-7304.
 
【9】ASANO T, NAKAMURA K, FUJII H, et al. Altered expression of topoisomerase Ⅱ alpha contributes to cross-resistant to etoposide K562/MX2 cell line by aberrant methylation[J]. Br J Cancer, 2005, 92(8):1486-1492.
 
【10】DAVID G L,YEGNASUBRAMANIAN S,KUMAR A, et al.MDR1 promoter hypermethylation in MCF-7 human breast cancer cells:changes in chromatin structure induced by treatment with 5-aza-cytidine[J]. Cancer Biol Ther, 2004, 3(6):540-548.
 
【11】GERSON S L. MGMT:its role in cancer aetiology and cancer therapeutics[J]. Nat Rev Cancer, 2004, 4(4):296-307.
 
【12】NATSUME A, ISHII D, WAKABAYASHI T, et al. IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide[J]. Cancer Res, 2005, 65(17):7573-7579.
 
【13】KUO M T. Roles of multidrug resistance genes in breast cancer chemoresistance[J]. Adv Exp Med Biol, 2007, 608:23-30.
 
【14】NAPIERALSKI R, OTT K, KREMER M, et al. Methylation of tumor-related genes in neoadjuvant-treated gastric cancer:relation to therapy response and clinicopathologic and molecular features[J]. Clin Cancer Res, 2007, 13(17):5095-5102.
 
【15】DAI Z, POPKIE A P, ZHU W G, et al. Bone morphogenetic protein 3B silencing in non-small-cell lung cancer[J]. Oncogene, 2004, 23(20):3521-3529.
 
【16】MARIATOS G, BOTHOS J, ZACHARATOS P, et al. Inactivating mutations targeting the chfr mitotic checkpoint gene in human lung cancer[J]. Cancer Res, 2003, 63(21):7185-7189.
 
【17】OGI K, TOYOTA M, MITA H, et al. Small interfering RNA-induced CHFR silencing sensitizes oral squamous cell cancer cells to microtubule inhibitors[J]. Cancer Biol Ther, 2005, 4(7):773-780.
 
【18】TANG T, KMET M, CORRAL L, et al. Testisin, a glycosyl-phosphatidylinositol-linked serine protease, promotes malignant transformation in vitro and in vivo[J]. Cancer Res, 2005, 65(3):868-878.
 
【19】DONNINGER H, VOS M D, CLARK G J. The RASSF1A tumor suppressor[J]. J Cell Sci, 2007, 120(Pt 18):3163-3172.
 
相关信息
   标题 相关频次
 抗凋亡基因bcl-2启动子CpG岛的高甲基化状态见于28.3%(13/46例)的膀胱癌患者尿沉淀细胞DNA
 14
 用尿沉淀细胞DNA甲基化状态的分析检测膀胱癌
 12
 TGF-β1基因rs2241715位点T/T基因型人群患HBV感染相关性疾患的风险更高
 8
 3株肺癌细胞中9个肿瘤相关基因的启动子甲基化状态和部分基因表达的相关性(英文)
 7
 腺瘤性结肠息肉病基因甲基化在肝细胞癌分子诊断中的价值
 6
 血浆Ras相关区域家族蛋白1A基因甲基化在肝细胞癌分子诊断中的价值
 6
 XRCC 1 Arg399Gln基因多态性对铂类药物化疗胃癌患者预后的影响
 4
 5'-氮杂-脱氧胞苷酸联合他莫昔芬对乳腺癌耐药相关蛋白介导雌激素受体α阴性乳腺癌细胞多柔比星耐药的影响
 4
 MicroRNA与DNA甲基化相互调节机制在肝细胞癌中的研究进展
 4
 长程多柔比星化疗富集乳腺肿瘤干细胞
 4
 含调肝散结方药物血清对乳腺癌MCF-7细胞增殖的影响及其作用机制的研究
 4
 乳腺癌中NDRG-1基因甲基化及其体外逆转研究
 4
 乳腺癌组织中p16基因变异及CpG岛甲基化状态的研究
 4
 乳腺浸润性导管癌及良性病变中ER基因的5'CpG岛甲基化状态
 4
 天花粉蛋白抑制人乳腺癌MDA-MB-231细胞生长及逆转syk基因甲基化的研究
 4
 微RNA-34a在乳腺癌中的表达及其基因启动子甲基化
 4
 紫杉醇诱导人乳腺癌细胞凋亡过程DNA甲基化水平检测
 4
 雌激素受体阳性乳腺癌他莫昔芬耐药机制的研究进展
 3
 肺癌中FHIT基因异常甲基化及其蛋白表达的意义
 3
 克服乳腺癌内分泌耐药的靶向治疗新进展
 3
 乳腺癌患者外周血DNA中PTPRO基因甲基化异常的检测及其临床意义
 3
 乳腺癌患者外周血DNA中PTPRO基因甲基化异常的检测及其临床意义
 3
 食管癌组织中金属硫蛋白3基因甲基化的地区性差异
 3
 ADAMTS18基因过表达可抑制人乳腺癌细胞的迁移与侵袭
 2
 Bcl-2基因多态性与乳腺癌临床生物学指标的关系
 2
 Cdc42基因在非甾体抗炎药抑制乳腺癌细胞丝状伪足形成中的作用
 2
 ECT2基因沉默调控人乳腺癌细胞增殖和凋亡及其机制探讨
 2
 EDN3基因抑制人乳腺癌细胞的迁移及侵袭
 2
 ER codon 325、PR+331G/A与乳腺癌关系的病例对照研究
 2
 Gadd45G基因在食管鳞癌组织中的异常甲基化及表达
 2

  热点专题


关于我们  |   联系我们  |   广告投放  |   《肿瘤》杂志社版权所有 《肿瘤》杂志社   © 中国 上海 2014.3
沪ICP备15036656号-2